03/25/2025
6:08 AM | Entrada Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/24/2025
6:06 AM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2025
3:32 PM | Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
6:02 AM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2025
6:07 AM | Entrada Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2025
6:16 AM | Entrada Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/24/2025
6:02 AM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
2:47 PM | Entrada Therapeutics (Subject)
ROCHE FINANCE LTD (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025
10:25 AM | Entrada Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SCHEDULE 13G | |
02/03/2025
6:05 AM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2024
4:00 PM | Entrada Therapeutics (Issuer)
EVNIN LUKE (Reporting)
Foley Todd (Reporting)
GADICKE ANSBERT (Reporting)
MPM Asset Management Investors BV2014 LLC (Reporting)
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC (Reporting)
MPM BioVentures 2014 GP LLC (Reporting)
MPM BioVentures 2014 LLC (Reporting)
MPM BioVentures 2014, L.P. (Reporting)
MPM BIOVENTURES 2018 , L.P. (0001729504) (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for TRDA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Entrada Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
12/12/2024
4:00 PM | Entrada Therapeutics (Issuer)
MPM BioVentures 2018 GP LLC (Reporting)
MPM BioVentures 2018 LLC (Reporting)
MPM BIOVENTURES 2018, L.P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
4:24 PM | Entrada Therapeutics (Issuer)
Sethuraman Natarajan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
4:26 PM | Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
3:47 PM | Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
3:49 PM | Entrada Therapeutics (Issuer)
Sethuraman Natarajan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
6:06 AM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2024
6:12 AM | Entrada Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/18/2024
3:31 PM | Entrada Therapeutics (Issuer)
Sethuraman Natarajan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
3:25 PM | Entrada Therapeutics (Subject)
Sethuraman Natarajan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/30/2024
3:32 PM | Dowden Nathan J (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
3:32 PM | Entrada Therapeutics (Issuer)
Sethuraman Natarajan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
3:33 PM | Dowden Nathan J (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
3:34 PM | Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
3:27 PM | Entrada Therapeutics (Subject)
WENTWORTH KORY JAMES (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2024
3:19 PM | Dowden Nathan J (Reporting)
Entrada Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2024
5:46 PM | Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
5:49 PM | Doshi Dipal (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
5:47 PM | Entrada Therapeutics (Issuer)
Sethuraman Natarajan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
5:48 PM | Dowden Nathan J (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:33 PM | Dowden Nathan J (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
3:25 PM | Dowden Nathan J (Reporting)
Entrada Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024
6:05 AM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
6:14 AM | Entrada Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/16/2024
3:42 PM | Doshi Dipal (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2024
3:43 PM | Entrada Therapeutics (Issuer)
Sethuraman Natarajan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/15/2024
3:30 PM | Doshi Dipal (Reporting)
Entrada Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024
3:34 PM | Entrada Therapeutics (Subject)
Sethuraman Natarajan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024
3:34 PM | Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
3:18 PM | Entrada Therapeutics (Subject)
WENTWORTH KORY JAMES (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/26/2024
3:53 PM | Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
“Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad) Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide.
It will give them unprecedented powers to control your bank account. Learn these 4 simple steps and protect your savings before it’s too late. |
06/26/2024
3:54 PM | BAKER BROS. ADVISORS LP (Filed by)
Entrada Therapeutics (Subject)
| Form SC 13D/A | |
06/24/2024
6:22 AM | Entrada Therapeutics (Filer)
| Form 424B5 | |
06/24/2024
6:25 AM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/24/2024
5:07 AM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2024
3:36 PM | Entrada Therapeutics (Issuer)
Thistle Mary (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:38 PM | Entrada Therapeutics (Issuer)
KIM PETER S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:39 PM | Entrada Therapeutics (Issuer)
PARMAR KUSH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:34 PM | Entrada Therapeutics (Issuer)
Zeiher Bernhardt G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:32 PM | Doshi Dipal (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:33 PM | Chapman Gina (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
3:05 PM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2024
3:31 PM | Entrada Therapeutics (Issuer)
KIM PETER S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
4:21 PM | Doshi Dipal (Reporting)
Entrada Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
4:26 PM | Entrada Therapeutics (Issuer)
Sethuraman Natarajan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
3:33 PM | Entrada Therapeutics (Issuer)
KIM PETER S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
3:35 PM | Entrada Therapeutics (Issuer)
KIM PETER S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
6:04 AM | Entrada Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
6:10 AM | Entrada Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/30/2024
3:17 PM | Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/29/2024
8:11 AM | Entrada Therapeutics (Filer)
| Form DEF 14A | |
04/29/2024
8:13 AM | Entrada Therapeutics (Filer)
| Form DEFA14A | |
04/29/2024
8:14 AM | Entrada Therapeutics (Filer)
| Form ARS | |
04/25/2024
3:30 PM | Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/24/2024
3:20 PM | Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/23/2024
3:18 PM | Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/19/2024
6:00 AM | Entrada Therapeutics (Filer)
| Form PRE 14A | |
04/18/2024
3:18 PM | Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2024
3:16 PM | Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/16/2024
3:18 PM | Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/11/2024
3:23 PM | Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024
3:35 PM | Entrada Therapeutics (Issuer)
KIM PETER S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
3:14 PM | Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/09/2024
3:12 PM | Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/08/2024
4:16 PM | Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/05/2024
3:17 PM | Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
